<VariationArchive VariationID="10256" VariationName="NM_000132.4(F8):c.4121_4124del (p.Ile1374fs)" VariationType="Deletion" Accession="VCV000010256" Version="6" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-06-23" DateCreated="2013-04-04" MostRecentSubmission="2024-06-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="25295" VariationID="10256">
      <GeneList>
        <Gene Symbol="F8" FullName="coagulation factor VIII" GeneID="2157" HGNC_ID="HGNC:3546" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154835792" stop="155022723" display_start="154835792" display_stop="155022723" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="154064062" stop="154250997" display_start="154064062" display_stop="154250997" Strand="-" />
          </Location>
          <OMIM>300841</OMIM>
          <Haploinsufficiency last_evaluated="2020-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=F8">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=F8">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000132.4(F8):c.4121_4124del (p.Ile1374fs)</Name>
      <CanonicalSPDI>NC_000023.11:154929665:TCTATCT:TCT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154929666" stop="154929669" display_start="154929666" display_stop="154929669" variantLength="4" positionVCF="154929665" referenceAlleleVCF="GTCTA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="154157941" stop="154157944" display_start="154157941" display_stop="154157944" variantLength="4" positionVCF="154157940" referenceAlleleVCF="GTCTA" alternateAlleleVCF="G" />
      </Location>
      <OtherNameList>
        <Name>F8, 4-BP DEL, FS</Name>
        <Name>NM_000132.3(F8):c.4121_4124del</Name>
        <Name>p.Ile1374fs</Name>
      </OtherNameList>
      <ProteinChange>I1374fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_555" sequenceAccession="LRG_555">
            <Expression>LRG_555:g.98055_98058del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.154157944_154157947del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.154157944_154157947del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.154929669_154929672del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.154929669_154929672del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011403.2" sequenceAccession="NG_011403" sequenceVersion="2" change="g.98055_98058del">
            <Expression>NG_011403.2:g.98055_98058del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000132.4" sequenceAccession="NM_000132" sequenceVersion="4" change="c.4121_4124del" MANESelect="true">
            <Expression>NM_000132.4:c.4121_4124del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000123.1" sequenceAccession="NP_000123" sequenceVersion="1" change="p.Ile1374fs">
            <Expression>NP_000123.1:p.Ile1374fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_555t1" sequenceAccession="LRG_555t1">
            <Expression>LRG_555t1:c.4121_4124del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_555p1" sequenceAccession="LRG_555p1" change="p.Ile1374fs">
            <Expression>LRG_555p1:p.Ile1374fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA255148" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="300841.0173" DB="OMIM" />
        <XRef Type="rs" ID="387906452" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000132.4(F8):c.4121_4124del (p.Ile1374fs) AND Hereditary factor VIII deficiency disease" Accession="RCV000010969" Version="7">
        <ClassifiedConditionList TraitSetID="2866">
          <ClassifiedCondition DB="MedGen" ID="C0019069">Hereditary factor VIII deficiency disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2024-02-09" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000132.4(F8):c.4121_4124del (p.Ile1374fs) AND multiple conditions" Accession="RCV002490352" Version="1">
        <ClassifiedConditionList TraitSetID="81995">
          <ClassifiedCondition DB="MedGen" ID="C0019069">Hereditary factor VIII deficiency disease</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C5676879">Thrombophilia, X-linked, due to factor 8 defect</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-08-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-09" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2013-04-04" MostRecentSubmission="2024-06-23">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17498081</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19369668</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20028422</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20102490</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29296726</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8307558</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9829908</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/eec8143e-0a98-4734-9318-ab3c2cdc0c32</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="2866" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2126" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hemophilia A</ElementValue>
                <XRef ID="MONDO:0010602" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary factor VIII deficiency disease</ElementValue>
                <XRef ID="28293008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hemophilia A, congenital</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hemophilia, classic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HEM A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Factor 8 deficiency, congenital</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Factor VIII deficiency, congenital</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AUTOSOMAL HEMOPHILIA A</ElementValue>
                <XRef Type="MIM" ID="134500" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HEMA</ElementValue>
                <XRef Type="MIM" ID="306700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hemophilia A is characterized by deficiency in factor VIII clotting activity that results in prolonged oozing after injuries, tooth extractions, or surgery, and delayed or recurrent bleeding prior to complete wound healing. The age of diagnosis and frequency of bleeding episodes are related to the level of factor VIII clotting activity. Individuals with severe hemophilia A are usually diagnosed during the first two years of life following oral or soft tissue bleeding either with procedures or due to a known family history of hemophilia. Without prophylactic treatment, individuals may average up to two to five spontaneous bleeding episodes each month including spontaneous joint bleeds or deep-muscle hematomas, and prolonged bleeding or excessive pain and swelling from minor injuries, surgery, and tooth extractions. Individuals with moderate hemophilia A seldom have spontaneous bleeding, although it varies between individuals; however, they do have prolonged or delayed bleeding after relatively minor trauma and are usually diagnosed before age five to six years; the frequency of bleeding episodes varies, usually from once a month to once a year. Individuals with mild hemophilia A do not have spontaneous bleeding episodes; however, without pre- and postoperative treatment, abnormal bleeding occurs with surgery or tooth extractions; the frequency of bleeding episodes varies widely, typically from once a year to once every ten years. Individuals with mild hemophilia A are often not diagnosed until later in life. Approximately 30% of heterozygous females have factor VIII clotting activity below 40% and are at risk for bleeding (even if males in the family are only mildly affected). After major trauma or invasive procedures, prolonged or excessive bleeding usually occurs, regardless of severity. In addition, 25% of heterozygous females with normal factor VIII clotting activity report an increased bleeding tendency.</Attribute>
                <XRef ID="NBK1404" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6591" />
                <XRef ID="6591" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301578</ID>
                <ID Source="BookShelf">NBK1404</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21654722</ID>
              </Citation>
              <Citation Type="general" Abbrev="UKHCDO, 2013">
                <ID Source="PubMed">23157203</ID>
              </Citation>
              <XRef ID="98878" DB="Orphanet" />
              <XRef ID="C0019069" DB="MedGen" />
              <XRef ID="MONDO:0010602" DB="MONDO" />
              <XRef Type="MIM" ID="134500" DB="OMIM" />
              <XRef Type="MIM" ID="306700" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="81995" Type="TraitChoice" ContributesToAggregateClassification="false">
            <Trait ID="61873" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Thrombophilia 13, X-linked, due to factor VIII defect</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">THROMBOPHILIA, X-LINKED, DUE TO FACTOR VIII DEFECT</ElementValue>
                <XRef Type="MIM" ID="301071" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300841.0272" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Thrombophilia, X-linked, due to factor 8 defect</ElementValue>
                <XRef ID="MONDO:0859082" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">THPH13</ElementValue>
                <XRef Type="MIM" ID="301071" DB="OMIM" />
              </Symbol>
              <XRef ID="C5676879" DB="MedGen" />
              <XRef ID="MONDO:0859082" DB="MONDO" />
              <XRef Type="MIM" ID="301071" DB="OMIM" />
            </Trait>
            <Trait ID="2126" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hemophilia A</ElementValue>
                <XRef ID="MONDO:0010602" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary factor VIII deficiency disease</ElementValue>
                <XRef ID="28293008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hemophilia A, congenital</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hemophilia, classic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HEM A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Factor 8 deficiency, congenital</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Factor VIII deficiency, congenital</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AUTOSOMAL HEMOPHILIA A</ElementValue>
                <XRef Type="MIM" ID="134500" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HEMA</ElementValue>
                <XRef Type="MIM" ID="306700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hemophilia A is characterized by deficiency in factor VIII clotting activity that results in prolonged oozing after injuries, tooth extractions, or surgery, and delayed or recurrent bleeding prior to complete wound healing. The age of diagnosis and frequency of bleeding episodes are related to the level of factor VIII clotting activity. Individuals with severe hemophilia A are usually diagnosed during the first two years of life following oral or soft tissue bleeding either with procedures or due to a known family history of hemophilia. Without prophylactic treatment, individuals may average up to two to five spontaneous bleeding episodes each month including spontaneous joint bleeds or deep-muscle hematomas, and prolonged bleeding or excessive pain and swelling from minor injuries, surgery, and tooth extractions. Individuals with moderate hemophilia A seldom have spontaneous bleeding, although it varies between individuals; however, they do have prolonged or delayed bleeding after relatively minor trauma and are usually diagnosed before age five to six years; the frequency of bleeding episodes varies, usually from once a month to once a year. Individuals with mild hemophilia A do not have spontaneous bleeding episodes; however, without pre- and postoperative treatment, abnormal bleeding occurs with surgery or tooth extractions; the frequency of bleeding episodes varies widely, typically from once a year to once every ten years. Individuals with mild hemophilia A are often not diagnosed until later in life. Approximately 30% of heterozygous females have factor VIII clotting activity below 40% and are at risk for bleeding (even if males in the family are only mildly affected). After major trauma or invasive procedures, prolonged or excessive bleeding usually occurs, regardless of severity. In addition, 25% of heterozygous females with normal factor VIII clotting activity report an increased bleeding tendency.</Attribute>
                <XRef ID="NBK1404" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6591" />
                <XRef ID="6591" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301578</ID>
                <ID Source="BookShelf">NBK1404</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21654722</ID>
              </Citation>
              <Citation Type="general" Abbrev="UKHCDO, 2013">
                <ID Source="PubMed">23157203</ID>
              </Citation>
              <XRef ID="98878" DB="Orphanet" />
              <XRef ID="C0019069" DB="MedGen" />
              <XRef ID="MONDO:0010602" DB="MONDO" />
              <XRef Type="MIM" ID="134500" DB="OMIM" />
              <XRef Type="MIM" ID="306700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="8049165" SubmissionDate="2024-06-20" DateLastUpdated="2024-06-23" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="eec8143e-0a98-4734-9318-ab3c2cdc0c32" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004363668" DateUpdated="2024-06-23" DateCreated="2024-02-14" Type="SCV" Version="2" SubmitterName="ClinGen Coagulation Factor Deficiency Variant Curation Expert Panel, Clingen" OrgID="509383" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-09">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/eec8143e-0a98-4734-9318-ab3c2cdc0c32</URL>
          </Citation>
          <Comment>The NM_000132.3(F8):c.4121_4124del (p.Ile1374fs) variant is a frameshift variant that is predicted to introduce a premature stop codon in exon 14 and expected to result in nonsense-mediated mRNA decay, which meets PVS1. It is reported in at least 7 patients with moderate or severe hemophilia A in the literature reviewed (PMID: 22103590, 20102490, 8307558, 9829908, 17498081, 20028422) meeting PS4_Very strong. There are additional probands with the variant reported in the EAHAD database, recorded from the literature. The variant is absent from gnomAD v2.1.1 and v3, which meets PM2_Supporting. In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F8: PVS1, PS4, PM2_Supporting.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen CoagFactor ACMG Specifications F8 V1.0.0</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/wvczdlfl/clingen_coagfactor_acmg_specifications_f8_v1.0.0.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="F8" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000132.3(F8):c.4121_4124del</Name>
            <Name>p.Ile1374fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.11:g.154929669_154929672del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0010602" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14216097</SubmissionName>
          <SubmissionName>SUB14549634</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="31196" SubmissionDate="2012-09-14" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300841.0173_HEMOPHILIA A" title="F8, 4-BP DEL, FS_HEMOPHILIA A" />
        <ClinVarAccession Accession="SCV000031196" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1993-12-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with severe hemophilia A (306700), Lin et al. (1993) identified the deletion of 4 nucleotides (TAGA) resulting in a frameshift downstream from codons 1355-6 in exon 14.</Attribute>
              <Citation>
                <ID Source="PubMed">8307558</ID>
              </Citation>
              <XRef DB="OMIM" ID="306700" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="F8" />
          </GeneList>
          <Name>F8, 4-BP DEL, FS</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DEL, FS</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300841.0173" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HEMOPHILIA A</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2812441" SubmissionDate="2020-05-15" DateLastUpdated="2020-11-19" DateCreated="2020-11-19">
        <ClinVarSubmissionID localKey="NM_000132.3:c.4121_4124del|OMIM:306700" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001424864" DateUpdated="2020-11-19" DateCreated="2020-11-19" Type="SCV" Version="1" SubmitterName="Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico" OrgID="507580" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-06-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20028422</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17498081</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9829908</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8307558</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20102490</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29296726</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19369668</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Causasians</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="F8" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000132.3:c.4121_4124del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="306700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7452716</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5433874" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000132.3:c.4121_4124del|OMIM:301071;306700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002776346" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000132.3:c.4121_4124del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="301071" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="306700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2812441" TraitType="Disease" MappingType="XRef" MappingValue="306700" MappingRef="OMIM">
        <MedGen CUI="C0019069" Name="Hereditary factor VIII deficiency disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5433874" TraitType="Disease" MappingType="XRef" MappingValue="306700" MappingRef="OMIM">
        <MedGen CUI="C0019069" Name="Hereditary factor VIII deficiency disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8049165" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0010602" MappingRef="MONDO">
        <MedGen CUI="C0019069" Name="Hereditary factor VIII deficiency disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5433874" TraitType="Disease" MappingType="XRef" MappingValue="301071" MappingRef="OMIM">
        <MedGen CUI="C5676879" Name="Thrombophilia, X-linked, due to factor 8 defect" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="31196" TraitType="Disease" MappingType="Name" MappingValue="HEMOPHILIA A" MappingRef="Preferred">
        <MedGen CUI="C0019069" Name="Hereditary factor VIII deficiency disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

